DRMA Projected Dividend Yield
Dermata Therapeutics Inc ( NASDAQ : DRMA )Dermata Therapeutics is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Co.'s main product candidate, DMT310, is intended to utilize its Spongilla technology for a once weekly treatment of a variety of skin diseases with its initial focus being for the treatment of acne vulgaris. Co.'s second product candidate utilizing its Spongilla technology is its combination treatment, DMT410. DMT410 is intended to consist of one treatment of Co.'s sponge powder followed by one topical application of botulinum toxin for delivery into the dermis. 20 YEAR PERFORMANCE RESULTS |
DRMA Dividend History Detail DRMA Dividend News DRMA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |